PIPages
Labs

Fabiano Nery

University of Cincinnati, OH·Medicine & Clinical Research

Depression and bipolar disorder usually begin in the teens and early twenties. Young people with depression are often prescribed selective serotonin reuptake inhibitors (SSRIs), the standard antidepressants.

Fields

Medicine & Clinical Research

Neuroscience

Psychology

Topics

depression

major depressive disorder

bipolar disorder

Grants
1 known grant, through Mar 2030

What they work on

  1. Measure how glutamate levels in the left ventrolateral prefrontal cortex change after 8 weeks of N-acetylcysteine (NAC) and/or mindfulness-based cognitive therapy in youth aged 15–24 with mild depression, using proton MR spectroscopy.
  2. Determine how functional connectivity within prefrontal–limbic circuits and large-scale emotion and attention networks changes with NAC and/or mindfulness-based cognitive therapy, using resting-state fMRI.
  3. Compare four arms of a double-blind, placebo-controlled trial in 160 medication-free depressed youth to test whether NAC and mindfulness-based cognitive therapy have additive or synergistic effects on the brain.
  4. Explore whether brain and blood biomarkers of oxidative stress and inflammation, measured at baseline and endpoint, predict which depressed youth respond to NAC, mindfulness therapy or both.

More about the research

Yet youth are especially prone to side effects such as switching into mania, irritability, agitation and suicidal thoughts. This is a particular concern for those whose parent or sibling has bipolar disorder. Safer, effective first treatments are needed.

Why it matters

Youth with depression, especially those with a close relative who has bipolar disorder, are at risk of harmful reactions to standard antidepressants. Showing whether NAC and mindfulness therapy change brain chemistry and connectivity, alone or together, and which blood or brain markers predict response, could provide the evidence needed for larger trials. Those trials could test these interventions as safer early treatment options for this high-risk group.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Prefrontal glutamatergic modulation by N-acetylcysteine and mindfulness-based cognitive therapy for mild depression in youth

NIH · Apr 2025 – Mar 2030

Closest labs

Melissa Delbello

University of Cincinnati, OH·Neuroscience

Track four-year trajectories of ventral prefrontal network connectivity, brain circuits for mood and risk-reward processing, in youth with versus without a family history of bipolar I disorder.

Manish Jha

University of Texas Southwestern Medical Center, TX·Neuroscience·Early-career

Identify patterns of resting-state functional connectivity linked to irritability, using 7 Tesla fMRI in 30 healthy adults and 60 adults with major depressive disorder.

Susan Whitfield-Gabrieli

Northeastern University, MA·Psychology

Test whether mindfulness-based real-time fMRI neurofeedback engages its intended brain target by reducing hyperconnectivity within the default mode network, the circuit active during inward self-focused thought, in adolescents aged 13 to 18 with major depressive disorder.

The school

University of Cincinnati: 18 labs on PI Pages, $740M a year on research, 275 research doctorates a year.

More about University of Cincinnati

Reach out

A start for your email. Fill in the brackets.